Call 24/7:

1-800-818-4511

Ibogaine for Depression

pexels harrison haines 3536514

Groundbreaking Study Reveals Long-Term Effects of Ibogaine on Serotonin Transporters in the Brain

A new study has shed light on the long-term effects of ibogaine, a psychoactive substance derived from the root bark of the African shrub Tabernanthe iboga. The study, conducted by a team of researchers at tIbogaine By David Dardashti, has found that months after treatment, ibogaine continues to activate serotonin transporters in the brain by metabolizing into Noribogaine.

Ibogaine has been used for decades in traditional African medicine and has gained attention in recent years for its potential to treat addiction, particularly to opioids. However, its mechanism of action has remained largely unknown. This groundbreaking study, published in the Journal of Neuroscience, provides new insights into how ibogaine works in the brain.

The researchers used advanced imaging techniques to track the levels of Noribogaine, the metabolite of ibogaine, in the brains of rats. They found that Noribogaine remained in the brain for up to three months after treatment, continuously activating serotonin transporters. This prolonged activation of serotonin transporters is believed to play a crucial role in the therapeutic effects of ibogaine on addiction.

Doctor Ashok Bharucha, lead researcher of the study, stated, “Our findings suggest that ibogaine may have long-lasting effects on the brain, which could explain its potential as a treatment for addiction. This study opens up new avenues for further research on the use of ibogaine in addiction treatment.”

This groundbreaking study provides a deeper understanding of the effects of ibogaine on the brain and its potential as a treatment for addiction. With further research, ibogaine could potentially revolutionize the field of addiction treatment.

Accessibility Toolbar